The NAMLG’s Educational Working Group is hosting a webinar on September 24, 2024, from 15:00 to 16:30 CEST. The webinar will provide the latest insights on using Aza-Ven in AML treatment including discussions from a Nordic perspective. Topics will include its application as a first-line treatment, dosing optimizations, and strategies for maintenance therapy. You can […]
Find more info in this flyer. Location: Aarhus University Hospital AUH SYD, auditorium C114-101. Indgang C, C110 or join online. Please send your registration for the meeting before October 16th to Daniel Tuyet Kristensen (dankrt@rm.dk). Please note if you will participate in person or online to receive a link.
This Servier arranged webinar is for hematologists. The agenda for the webinar is: 12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier 12:05-12:30 – Prof. Dr. Michael Heuser - Will present the AGILE study and the clinical implications of the study results. 12:30-12:45 – Docent Vladimir Lazarevic - Focusing on treatment of mIDH1 AML patients […]
MNSCT 2024 Meeting Date: 21 November 2024 Venue: Grand Hotel, Lund, Sweden or online Registration: https://mkon.nu/mnsct_2024/registration Program 12:00-12:55 Lunch, registration starts at 11.45 13:00-13:05 Welcome/Introduction (Assoc. Prof. Andreas Björklund, Stockholm, Assoc. Prof. Jörg Cammenga, Lund) Session 1: 13:05-13:45 Prof. Dr. Thomas Schröder, University Hospital Essen, Essen Germany -- “Pharmacological preemptive and prophylactic approaches to prevent/treat relapse of myeloid neoplasms after allo SCT” […]
You are cordially invited to the NAMLG Breakfast Meeting, held during ASH in San Diego. Date: Saturday, December 7th Time: 7:00 AM – 9:00 AM This event is generously sponsored by AbbVie. To register, please contact Bjørn Tore Gjertsen (Bjorn.Gjertsen@uib.no).
For Nordic AML physicians attending the Acute Leukemia Symposium ISALXIX in Munich 16-19th March 2025, You are cordially invited to a NAMLG Lunch Meeting in on Monday March 17th, 12.00-14.00. Find more info in this flyer.
The newly established Jebsen Centre for Myeloid Blood Cancer (c-myc) will have their first Annual c-myc Seminar as a full-day satellite to CCBIO’s 13th Annual Symposium and will showcase recent advancements in single-cell genomics, transcriptomics, proteomics, and preclinical trials, setting the stage for future clinical applications. The event will bring together leading researchers to explore […]
CCBIO has the pleasure of inviting you to the 13th CCBIO Annual Symposium May 13-14, and now, PREFINAL PROGRAM is available. To participate, please register within April 1. There will be a strong scientific program including a range of international speakers, among them Sir David Lane, Eva Hellström-Lindberg, Theodoros Foukakis, Anna Dimberg, Steinar Ø. Thoresen, Gema Moreno-Bueno and Jean […]
The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current diagnostics and therapeutics, the latest with regard to MRD as well as clinically inclined discussions on emergencies and infectious problems in AML. The AML Course […]
It's an open meeting for clinicians and preclinical researchers but meant for those that are actually interested to take part in future Nordic collaborative TP53 related myeloid research. The meeting will be held at Hotel Norge, Bergen, in connection with the NAMLG meeting, Room number will be announced at the hotel reception. The meeting will […]
Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.